Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Dunning

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1James Onuffer, Margaret A McCarrick, Laura Dunning, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2006
CCR5 receptor antagonists: discovery and SAR study of guanylhydrazone derivativesRobert G Wei, Damian O Arnaiz, Yuo-Ling Chou, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2007
CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivativesShou-Fu Lu, Binglong Chen, Dave Davey, et al.
Molecular Pharmacology|October 14, 2005
Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8Christopher A Haskell, Richard Horuk, Meina Liang, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2018
Reversible, orally available ADP receptor (P2Y<sub>12</sub>) antagonists Part I: Hit to lead processImadul Islam, Shendong Yuan, Robert G Wei, et al.
The Journal of Biological Chemistry|July 14, 2006
Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validationNagarajan Vaidehi, Sabine Schlyer, Rene J Trabanino, et al.
Haematologica|May 14, 2026
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencingWendy Osborne, Euan Haynes, William Wilson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1James Onuffer, Margaret A McCarrick, Laura Dunning, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2006
CCR5 receptor antagonists: discovery and SAR study of guanylhydrazone derivativesRobert G Wei, Damian O Arnaiz, Yuo-Ling Chou, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2007
CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivativesShou-Fu Lu, Binglong Chen, Dave Davey, et al.
Molecular Pharmacology|October 14, 2005
Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8Christopher A Haskell, Richard Horuk, Meina Liang, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2018
Reversible, orally available ADP receptor (P2Y<sub>12</sub>) antagonists Part I: Hit to lead processImadul Islam, Shendong Yuan, Robert G Wei, et al.
The Journal of Biological Chemistry|July 14, 2006
Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validationNagarajan Vaidehi, Sabine Schlyer, Rene J Trabanino, et al.
Haematologica|May 14, 2026
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencingWendy Osborne, Euan Haynes, William Wilson, et al.
Pageof 1